As Director of Science at Biotimize, a leading CDMO committed to biotechnology innovation, my role centers on optimizing bioproduction processes and strategically advancing biopharmaceutical development. My mission is to leverage cutting-edge science to make a transformative impact on global health.Biopharmaceutical Development: I lead the optimization of bioproduction processes, focusing on cell cultivation, recombinant protein expression, and purification. I aim to ensure our biopharmaceutical products are of the highest quality, adhering to rigorous industry standards.GMP Facility Planning: I oversee the planning and development of Biotimize's future GMP facilities. This involves designing state-of-the-art facilities that meet international regulatory requirements, ensuring we maintain the highest standards of quality and safety in biopharmaceutical production.Project Management: I manage a diverse portfolio of projects, coordinating resources, timelines, and teams to ensure successful project delivery. My approach integrates efficiency and precision, striving to exceed expectations and achieve excellence.Team Leadership: I lead and motivate multidisciplinary teams, fostering a culture of collaboration and innovation. By promoting an environment that values technical expertise and operational excellence, I drive our teams to achieve new levels of success in research and production.Opportunity Identification: I actively seek and develop new strategic partnerships. This includes crafting detailed proposals and formulating scientific strategies that align with market demands and emerging trends, positioning Biotimize as a leader in biotechnology.At Biotimize, we are dedicated to democratizing access to advanced science and transformative cures. Our commitment is to turn innovative ideas into tangible treatments that can make a meaningful difference in the world. Through our work, we aim to shape the future of biotechnology and improve lives globally.

I was responsible for generating regulatory documents for Good Manufacturing Practices (GMP) in the production of biosimilars, including monoclonal antibodies and blood coagulation factors. I oversaw and executed the upstream processes of antibody production in an industrial facility, ensuring GMP compliance. I identified and addressed challenges related to cell growth, contamination, and oxygen availability.I designed experiments for the development of new biosimilars, from clone isolation to process scale-up in single-use systems up to 500 L. I employed statistical tools, such as Design of Experiments (DoE), to enhance protein production and product quality.In addition to production and regulatory activities, I led a team, guiding them toward common goals. This role involved managing people and navigating team dynamics, providing significant learning experiences in team management.Responsibilities:Cell cultureCell transformationAdaptation to serum-free media and suspensionBioassaysGlycosylation analysesMetabolic analysesProtein expression optimizationApplication of DoEMonoclonal antibody productionOperation of bioreactors (Fed-batch, batch, and perfusion systems)Single-use systems up to 500 LGMP complianceSOP development and trainingBiopharmaceutical registrationIndustrial productionTeam coordinationExperimental planningReport and validation document preparation

I worked in projects of alcoholic fermentation at the R&D department. The aim of the activities was to optimize the production of bioethanol using by-products from sugar production as substrate.I was always used to work in the academic environment and this internship was my first corporative experience. Besides, It was also my first abroad experience. Even though my theoretical knowledge was well established, I had to adjust to the new culture and to the language. Positively, with this opportunity, I learned abilities far over the technical knowledge, I improved my English and German skills and became more organized.

The work was developed at the Department of Quality Control for products derived from the milling of corn. The activities were physicochemical analyses of the processed corn seeds.